199 related articles for article (PubMed ID: 15450411)
1. Spontaneous and induced chromosomal damage and mutations in Bloom Syndrome mice.
Wang Y; Heddle JA
Mutat Res; 2004 Oct; 554(1-2):131-7. PubMed ID: 15450411
[TBL] [Abstract][Full Text] [Related]
2. Small scale genetic alterations contribute to increased mutability at the X-linked Hprt locus in vivo in Blm hypomorphic mice.
Tereshchenko IV; Chen Y; McDaniel LD; Schultz RA; Tischfield JA; Shao C
DNA Repair (Amst); 2010 May; 9(5):551-7. PubMed ID: 20299287
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of in vivo mutations induced by N-ethyl-N-nitrosourea in the autosomal Tk and the X-linked Hprt genes of mouse lymphocytes.
Dobrovolsky VN; Chen T; Heflich RH
Environ Mol Mutagen; 1999; 34(1):30-8. PubMed ID: 10462721
[TBL] [Abstract][Full Text] [Related]
4. Characteristic association between K-ras gene mutation with loss of heterozygosity in X-ray-induced thymic lymphomas of the B6C3F1 mouse.
Shimada Y; Nishimura M; Kakinuma S; Takeuchi T; Ogiu T; Suzuki G; Nakata Y; Sasanuma S; Mita K; Sado T
Int J Radiat Biol; 2001 Apr; 77(4):465-73. PubMed ID: 11304438
[TBL] [Abstract][Full Text] [Related]
5. Enhanced tumor formation in mice heterozygous for Blm mutation.
Goss KH; Risinger MA; Kordich JJ; Sanz MM; Straughen JE; Slovek LE; Capobianco AJ; German J; Boivin GP; Groden J
Science; 2002 Sep; 297(5589):2051-3. PubMed ID: 12242442
[TBL] [Abstract][Full Text] [Related]
6. [Studies on gene mutation and micronucleus formation induced by ethylnitrosourea (ENU) in transgenic mice in vivo].
Cao J; Yin M; Chen J; Xu S
Zhonghua Yu Fang Yi Xue Za Zhi; 2000 Jan; 34(1):28-30. PubMed ID: 11860893
[TBL] [Abstract][Full Text] [Related]
7. Bloom syndrome: is the gene mapped to the point?
Bamezai R
Indian J Exp Biol; 1996 Apr; 34(4):298-301. PubMed ID: 8698416
[TBL] [Abstract][Full Text] [Related]
8. Transmission of mutations in the lacI transgene to the offspring of ENU-treated Big Blue male mice.
Barnett LB; Tyl RW; Shane BS; Shelby MD; Lewis SE
Environ Mol Mutagen; 2002; 40(4):251-7. PubMed ID: 12489115
[TBL] [Abstract][Full Text] [Related]
9. Coinheritance of BRCA1 and BRCA2 mutations with Fanconi anemia and Bloom syndrome mutations in Ashkenazi Jewish population: possible role in risk modification for cancer development.
Koren-Michowitz M; Friedman E; Gershoni-Baruch R; Brok-Simoni F; Patael Y; Rechavi G; Amariglio N
Am J Hematol; 2005 Mar; 78(3):203-6. PubMed ID: 15726604
[TBL] [Abstract][Full Text] [Related]
10. Frequency and spectrum of ENU-induced mutation in the Phi X174 transgene in mouse splenic lymphocytes and their significance to spontaneous transgenic rodent mutation frequencies.
Valentine CR; Rainey HF; Farrell JM; Shaddock JG; Dobrovolsky VN; Delongchamp RR
Mutagenesis; 2008 Sep; 23(5):383-97. PubMed ID: 18504270
[TBL] [Abstract][Full Text] [Related]
11. Carcinogen-specific targeting of chromosome 12 for loss of heterozygosity in mouse lung adenocarcinomas: implications for chromosome instability and tumor progression.
Herzog CR; Bodon N; Pittman B; Maronpot RR; Massey TE; Anderson MW; You M; Devereux TR
Oncogene; 2004 Apr; 23(17):3033-9. PubMed ID: 14755239
[TBL] [Abstract][Full Text] [Related]
12. Bloom syndrome and Fanconi's anemia: rate and ethnic origin of mutation carriers in Israel.
Peleg L; Pesso R; Goldman B; Dotan K; Omer M; Friedman E; Berkenstadt M; Reznik-Wolf H; Barkai G
Isr Med Assoc J; 2002 Feb; 4(2):95-7. PubMed ID: 11876000
[TBL] [Abstract][Full Text] [Related]
13. Relatively common mutations of the Bloom syndrome gene in the Japanese population.
Kaneko H; Isogai K; Fukao T; Matsui E; Kasahara K; Yachie A; Seki H; Koizumi S; Arai M; Utunomiya J; Miki Y; Kondo N
Int J Mol Med; 2004 Sep; 14(3):439-42. PubMed ID: 15289897
[TBL] [Abstract][Full Text] [Related]
14. The cII locus in the MutaMouse system.
Swiger RR; Cosentino L; Shima N; Bielas JH; Cruz-Munoz W; Heddle JA
Environ Mol Mutagen; 1999; 34(2-3):201-7. PubMed ID: 10529745
[TBL] [Abstract][Full Text] [Related]
15. Cancer predisposition caused by elevated mitotic recombination in Bloom mice.
Luo G; Santoro IM; McDaniel LD; Nishijima I; Mills M; Youssoufian H; Vogel H; Schultz RA; Bradley A
Nat Genet; 2000 Dec; 26(4):424-9. PubMed ID: 11101838
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of potential human carcinogens using B6.129tm1Trp53 heterozygous null mice and loss of heterozygosity at the Trp53 locus.
French JE
IARC Sci Publ; 2004; (157):271-87. PubMed ID: 15055301
[TBL] [Abstract][Full Text] [Related]
17. Large deletions at the HPRT locus associated with the mutator phenotype in a Bloom's syndrome lymphoblastoid cell line.
Tachibana A; Tatsumi K; Masui T; Kato T
Mol Carcinog; 1996 Sep; 17(1):41-7. PubMed ID: 8876674
[TBL] [Abstract][Full Text] [Related]
18. Frequent retention of heterozygosity for point mutations in p53 and Ikaros in N-ethyl-N-nitrosourea-induced mouse thymic lymphomas.
Kakinuma S; Nishimura M; Kubo A; Nagai JY; Amasaki Y; Majima HJ; Sado T; Shimada Y
Mutat Res; 2005 May; 572(1-2):132-41. PubMed ID: 15790496
[TBL] [Abstract][Full Text] [Related]
19. Heterozygosity for the BLM(Ash) mutation and cancer risk.
Cleary SP; Zhang W; Di Nicola N; Aronson M; Aube J; Steinman A; Haddad R; Redston M; Gallinger S; Narod SA; Gryfe R
Cancer Res; 2003 Apr; 63(8):1769-71. PubMed ID: 12702560
[TBL] [Abstract][Full Text] [Related]
20. Effect of p53 haploinsufficiency on melphalan-induced genotoxic effects in mouse bone marrow and peripheral blood.
Ranaldi R; Palma S; Tanzarella C; Lascialfari A; Cinelli S; Pacchierotti F
Mutat Res; 2007 Feb; 615(1-2):57-65. PubMed ID: 17109898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
